Close
Presentations (slides, Video) and Abstract are available to GBCC Sign-up members.
You can access after log-in.
Program
Scientific Program
Program at a Glance
Scientific Program
Invited Speakers
08:30-09:15
  • Satellite Symposium 2: 
    Pfizer Korea46
  • Venue:  RM 1(Vista 1+2)
Moderators
  • TBD
     (, )
Speakers
  • Palbociclib: Added Value of Long-term Efficacy, Safety and Real-world Data
    Kyung-Hun Lee
     (Seoul National Univ. Hospital, Korea)
09:30-10:15
  • Plenary Lecture 3
    3
  • Venue:  RM 1(Vista 1+2)
Moderators
  • Gyungyub Gong
     (ASAN Medical Center, Korea)
Speakers
  • Genomic Biology of Triple Negative Breast Cancer
    Edison Liu
     (The Jackson Laboratory, U.S.A.)
10:30-11:45
  • Symposium 5: 
    Single Cell Proteogenomic and Translational Research in Breast Cancer10
  • Venue:  RM 1(Vista 1+2)
Moderators
  • Andi K. Cani
     (Univ. of Michigan, U.S.A.)
  • Eugene C. Yi
     (Seoul National Univ. , Korea)
Speakers
  • Single Cell Genomics in Breast Cancer
    Amos Lee
     (Seoul National Univ., Korea)
  • Single Cell Proteomic Technology and Future
    Junho Park
     (CHA Univ. College of Medicine, Korea)
  • Single Cell Genomics of Circulating Tumor Cells in Breast Cancer
    Andi K. Cani
     (Univ. of Michigan, U.S.A.)
  • Panel Discussion 4: 
    Treatment Dilemma in the Management of Breast Cancer18
  • Venue:  RM 2(Vista 3)
Moderators
  • Byung Joo Chae
     (Samsung Medical Center, Korea)
  • Mehra Golshan
     (Yale School of Medicine, U.S.A.)
Speakers
  • Clinical Staging in Breast Cancer Patients Undergoing Neoadjuvant Treatment
    Han-Byoel Lee
     (Seoul National Univ. Hospital, Korea)
  • Can cT3/4 Breast Cancer be Safely Treated with Breast Conserving Surgery After Neoadjuvant Treatment?
    Mehra Golshan
     (Yale School of Medicine, U.S.A.)
  • Is Sentinel LN Biopsy Feasible in Clinical N2-3 Patients After Neoadjuvant Treatment?
    Jean-Francois Boileau
     (Jewish General Hospital, McGill Univ., U.S.A.)
  • Education Session 4: 
    Update of HER2+ Breast Cancer Treatment24
  • Venue:  RM 3(Walker Hall 1)
Moderators
  • Kyung Hae Jung
     (ASAN Medical Center, Korea)
  • Makiko Ono
     (The Cancer Institute Hospital of JFCR, Japan)
Speakers
  • Systemic Treatment for HER2-positive Early Breast Cancer
    Jee Hung Kim
     (Yonsei Univ. College of Medicine, Korea)
  • Systemic Treatment for HER2-positive Metastatic Breast Cancer
    Soo Chin Lee
     (National Univ. Cancer Institute, Singapore)
  • Overview and Management of Adverse Events of Anti-HER2 ADCs
    Makiko Ono
     (The Cancer Institute Hospital of JFCR, Japan)
  • Oral Presentation 5
    55
  • Venue:  RM 4(Walker Hall 2)
Speakers
  • COMPARATIVE MICROBIOME ANALYSIS OF THE CONTRACTED BREAST CAPSULE USING NEXT GENERATION SEQUENCING
    Tae Hyun Park
     (Kyungpook National Univ. School of Medicine, Korea)
  • FACTORS RELATED TO PREGNANCY RATE AND TIMING AFTER BREAST CANCER TREATMENT IN YOUNG PATIENTS.
    Young-Jin Lee
     (ASAN Medical Center, Korea)
  • PRELIMINARY EFFICACY OF NEOADJUVANT NAB-PACLITAXEL AND PEMBROLIZUMAB-CONTAINING REGIMENS IN EARLY STAGED TRIPLE NEGATIVE BREAST CANCER (ETNBC) THERAPY
    Sum Lung Jeffrey Wong
     (Queen Mary Hospital, Hong Kong)
  • DP103-REGULATED P53-SUMO/ACETYLATION SWITCH DETERMINES RESPONSE TO DOCETAXEL IN ERΑ-POSITIVE BREAST CANCER
    Alan Prem Kumar
     (National Univ. of Singapore, Singapore)
  • KEY REGULATORS OF CHOLESTEROL AND LIPID METABOLISM AGGRAVATE BREAST CANCER
    Sakshi Shukla
     (All India Institute of Medical Sciences, New Delhi, India)
  • PATTERN AND COMPLICATION OF RECONSTRUCTED BREAST CANCER PATIENTS WHO RECEIVED POSTMASTECTOMY RADIOTHERAPY IN THE NATIONAL HEALTH INSURANCE SERVICE COHORT 
    Hyejo Ryu
     (Seoul National Univ. College of Medicine, Korea)
  • MULTIDIMENSIONAL LONGITUDINAL ASSESSMENT OF TOXICITY AND COSMESIS AFTER HYPOFRACTIONATED WHOLE-BREAST RADIOTHERAPY FOR BREAST CANCER AMONG A PROSPECTIVE COHORT OF KOREAN WOMEN: A PRELIMINARY RESULT
    Nalee Kim
     (Samsung Medical Center, Korea)
  • IMPACT OF SURGICAL FACTORS ON AESTHETIC OUTCOME AFTER BREAST CONSERVATION THERAPY: A PROSPECTIVE COHORT STUDY
    Shraddha Kenekar
     (Tata Memorial Center, India)
  • BIODEGRADEBLE AND REDOX-RESPONSIVE NANOPARTICLE PLATFORM WITH TROP2 ANTIBODY LINKAGE FOR RNA INTERFERENCE TARGETING LNCRNA MNX1-AS1 TO REDUCE RADIO-RESISTANCE IN TRIPLE NEGATIVE BREAST CANCER
    Qingjian Li
     (Sun Yat-sen Memorial Hospital, China)
  • Nursing Session 1 (Kor.): 
    The Managements for Cognitive Impairment Related to Breast Cancer33
  • Venue:  RM 5(Art Hall)
Moderators
  • Eun-Young Jun
     (Daejeon Univ., Korea)
  • Nayeon Kim
     (Samsung Medical Center, Korea)
Speakers
  • The Impact of Chemotherapy on Cognitive Impairments: Evidence and Implications
    Hee-Ju Kim
     (The Catholic Univ. of Korea, Korea)
  • The Cognitive Impairment in Breast Cancer Patients Undergoing Therapy
    Hyejin Cho
     (Ewha Womans Univ. Seoul Hospital, Korea)
  • Beneficial Effects of Exercise on Cancer-related Cognitive Impairment with Breast Cancer Patients
    Seung-Soo Baek
     (Sangmyung Univ., Korea)
12:00-12:45
  • Plenary Lecture 4
    4
  • Venue:  RM 1(Vista 1+2)
Moderators
  • In Ah Kim
     (Seoul National Univ. Bundang Hospital, Korea)
Speakers
  • Breast-Cancer Related Lymphedema: Myths, Facts, Risk Factors and New Approach
    Alphonse Taghian
     (Massachusetts General Hospital, U.S.A.)
13:00-13:45
  • Satellite Symposium 3: 
    Lilly Korea47
  • Venue:  RM 1(Vista 1+2)
Moderators
  • TBD
     (, )
Speakers
  • Take Hope Further for HR+HER2-high-risk Early Breast Cancer Patients with Abemiciclib
    Nadia Harbeck
     (LMU Univ. Hospital, Germany)
14:00-14:45
  • Plenary Lecture 5
    5
  • Venue:  RM 1(Vista 1+2)
Moderators
  • Joon Jeong
     (Gangnam Severance Hospital, Korea)
Speakers
  • Escalation and De-escalation of Breast Cancer Treatment
    Michael Gnant
     (Medical Univ. of Vienna, Austria)
15:00-16:15
  • Symposium 6: 
    The Role of Imaging in the Personalized Treatment11
  • Venue:  RM 1(Vista 1+2)
Moderators
  • Woo Kyung Moon
     (Seoul National Univ. Hospital, Korea)
  • Bo Kyoung Seo
     (Korea Univ. Ansan Hospital, Korea)
Speakers
  • The Role of Imaging for the Management of DCIS
    Mami Iima
     (Kyoto Univ. Hospital, Japan)
  • The Role of DW-MRI in the Personalized Screening and Diagnosis
    Savannah Partridge
     (Univ. of Washington, U.S.A.)
  • Quantitative Imaging in Outcome Prediction of Breast Cancer
    Vivian Youngjean Park
     (Yonsei Univ. College of Medicine, Korea)
  • Panel Discussion 5: 
    Locoregional Treatment for Advanced/Recurrent Breast Cancer19
  • Venue:  RM 2(Vista 3)
Moderators
  • Seung Ki Kim
     (CHA Bundang Medical Center, Korea)
  • Andreas Karakatsanis
     (Uppsala Univ. Hospital, Sweden)
Speakers
  • Surgical Extent After Neoadjuvant Chemotherapy
    Geok Hoon Lim
     (KK Women's and Children's Hospital, Singapore)
  • Role of Repeat Breast-conserving Surgery for the Management of Ipsilateral Breast Cancer Recurrence
    Andreas Karakatsanis
     (Uppsala Univ. Hospital, Sweden)
  • Radiation Therapy According to Residual Tumor Volume After Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer
    Sung-Ja Ahn
     (Chonnam National Univ. Medical School, Korea)
  • Education Session 5: 
    Liquid Biopsy: New Era of Cancer Management25
  • Venue:  RM 3(Walker Hall 1)
Moderators
  • Keun Seok Lee
     (National Cancer Center, Korea)
  • Kan Yonemori
     (National Cancer Center Hospital, Japan)
Speakers
  • Basic Technology of Liquid Biopsy
    Eunhae Cho
     (GC Genome, Korea)
  • Clinical Utility of Detection of Early Recurrence or Minimal Residual Disease Using Liquid Biopsy in Early Breast Cancer
    Kan Yonemori
     (National Cancer Center Hospital, Japan)
  • Current Advances of Liquid Biopsy in Tumor Burden Dynamics, Response Monitoring and Prognostic Marker in Metastatic Breast Cancer
    Jisun Kim
     (ASAN Medical Center, Korea)
  • Nursing Session 2 (Kor.): 
    Living and Care as Women with Hereditary Breast Cancer34
  • Venue:  RM 5(Art Hall)
Moderators
  • Mi Young Kang
     (Daerim St. Mary's Hospital, Korea)
  • Insook Lee
     (Changwon National Univ., Korea)
Speakers
  • An Overview of Genetic Counseling for Hereditary Breast and Ovarian Cancer Syndrome
    Bom-Yi Lee
     (Daerim St. Mary's Hospital, Korea)
  • Genetic Counseling for Hereditary Breast Cancer Patients
    Ji Hye Yang
     (ASAN Medical Center, Korea)
  • The Process of Choosing Cancer Risk-reducing Options in Women with Hereditary Breast Cancer: A Grounded Theory Study
    Sun-young Park
     (National Evidence-based Healthcare Collaborating Agency, Korea)
15:00-16:40
  • Endoscopic and Robotic Breast Surgery Session
    29
  • Venue:  RM 4(Walker Hall 2)
Moderators
  • Hyukjai Shin
     (Myongji Hospital, Korea)
  • Jesse Selber
     (Corewell Health, U.S.A.)
Speakers
  • Challenges of Robot Breast Surgery: Is there a Role for Robot Breast Surgery Outside of Clinical Trial?
    Moo Hyun Lee
     (Keimyung Univ. School of Medicine, Korea)
  • Challenges of Endoscopic Breast Surgery: Is It Just a Bridge for Robot Breast Surgery?
    Chi Wei Mok
     (Changi General Hospital, Singhealth Duke NUS Breast Centre, Singapore)
  • Current Status of Robot Breast Surgery
    Wen-Ling Kuo
     (Chang Gung Memorial Hospital, Taiwan)
  • Robot Surgery for Breast Reconstruction
    Jesse Selber
     (Corewell Health, U.S.A.)
16:30-17:45
  • Symposium 7: 
    PMRT/RNI in the Modern Era12
  • Venue:  RM 1(Vista 1+2)
Moderators
  • Chang-Ok Suh
     (CHA Bundang Medical Center, Korea)
  • Kyubo Kim
     (Ewha Womans Univ. Mokdong Hospital, Korea)
Speakers
  • Personalization of PMRT in the Modern Era
    Meena S. Moran
     (Yale School of Medicine, U.S.A.)
  • The Benefit of PMRT for Low Nodal Burden Breast Cancer in the Modern Treatment Era
    Kyung Hwan Shin
     (Seoul National Univ. Hospital, Korea)
  • Incorporation of New Systemic Agents in Patients Treated with PMRT
    Alice Y. Ho
     (Duke Univ., U.S.A.)
  • Debate Session
    27
  • Venue:  RM 2(Vista 3)
Moderators
  • Jae Ho Jeong
     (ASAN Medical Center, Korea)
Speakers
  • Role of Platinum Agent in Early Triple Negative Breast Cancer - Pros.
    Jieun Lee
     (The Catholic Univ. of Korea, Seoul St. Mary's Hospital, Korea)
  • Role of Platinum Agent in Early Triple Negative Breast Cancer - Cons.
    Min Hwan Kim
     (Yonsei Univ. College of Medicine, Korea)
  • Genomic Risk vs. Clinical Risk in Early-stage, HR+ Breast Cancer - Genomic risk
    Dae-Won Lee
     (Seoul National Univ. Hospital, Korea)
  • Genomic Risk vs. Clinical Risk in Early-stage, HR+ Breast Cancer - Clinical risk
    Tae-Kyung Robyn Yoo
     (ASAN Medical Center, Korea)
Panelist
  • -
    Ian Krop
     (Yale School of Medicine, U.S.A.)
  • Yeon Hee Park
     (Samsung Medical Center, Korea)
  • Soo Chin Lee
     (National Univ. Cancer Institute, Singapore)
  • Education Session 6: 
    Post-operative Management and Surveillance Strategies for Breast Cancer Patients26
  • Venue:  RM 3(Walker Hall 1)
Moderators
  • Tae Hyun Kim
     (Inje Univ. Busan Paik Hospital, Korea)
  • An-Chieh Feng
     (Tri-Service General Hospital, Taiwan)
Speakers
  • Surveillance Strategy Overview in Korea
    Hyeong-Gon Moon
     (Seoul National Univ. Hospital, Korea)
  • Post-operative Surveillance and Management for Breast Cancer Patients in Taiwan
    An-Chieh Feng
     (Tri-Service General Hospital, Taiwan)
  • The State-of-the-art Risk Prediction Tools and How They Apply to Asian Breast Cancer Screening Programs
    Jingmei Li
     (Genome Institute of Singapore, Singapore)
  • ABCN Business Meeting & Networking
    50
  • Venue:  RM 5(Art Hall)
16:50-17:50
  • OPBS Session
    28
  • Venue:  RM 4(Walker Hall 2)
Moderators
  • Eun-Kyu Kim
     (Seoul National Univ. Bundang Hospital, Korea)
  • Visnu Lohsiriwat
     (Siriraj Hospital, Mahidol Univ., Thailand)
Speakers
  • Oncoplastic breast surgery: Where are We?
    Ho Yong Park
     (Kyungpook National Univ. Chilgok Hospital, Korea)
  • Advanced Surgical Technic for Successful OPBS in Breast Cancer
    Visnu Lohsiriwat
     (Siriraj Hospital, Mahidol Univ., Thailand)
  • Evaluation of Breast Symmetry and Cosmesis for Dense Breast
    Jung Ho Lee
     (The Catholic Univ. of Korea Bucheon St. Mary's Hospital, Korea)
18:00-18:45
  • Satellite Symposium 4: 
    Novartis48
  • Venue:  RM 1(Vista 1+2)
Moderators
  • TBD
     (, )
Speakers
  • Optimal and Sequential Treatment Strategy for HR+ HER2- aBC Patients for Longer and Better Life
    Keun Seok Lee
     (National Cancer Center, Korea)



Global Breast Cancer Conference Secretariat

Partner I INTERCOM Convention Services, Inc. (Core PCO)

TOP